Document is current
Any future updates will be listed below
-
Authors
Rol, Álvaro
Todorovski, Toni http://orcid.org/0000-0002-9168-2830
Martin-Malpartida, Pau http://orcid.org/0000-0001-5867-5535
Escolà, Anna
Gonzalez-Rey, Elena
Aragón, Eric
Verdaguer, Xavier
Vallès-Miret, Mariona http://orcid.org/0000-0003-3712-1634
Farrera-Sinfreu, Josep
Puig, Eduard http://orcid.org/0000-0003-3506-2829
Fernández-Carneado, Jimena
Ponsati, Berta
Delgado, Mario http://orcid.org/0000-0003-1893-5982
Riera, Antoni http://orcid.org/0000-0001-7142-7675
Macias, Maria J. http://orcid.org/0000-0002-6915-963X
- License Information
-
More Information
Article History
Received: 21 November 2019
Accepted: 24 February 2021
First Online: 25 March 2021
Competing interests
: Analogue 5 is patented, EP 3046933 B1 (BCN PEPTIDES, S.A.) 2019-02-27, “Cortistatin analogues for the treatment of inflammatory and/or immune diseases”. All authors declare no other competing interests.
